Provexis (PXS) Competitors GBX 0.65 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors PXS vs. NSH, ALK, SHIP, TORO, CLCO, ICON, PAA, GEL, MMP, and AALShould you be buying Provexis stock or one of its competitors? The main competitors of Provexis include Norish (NSH), Alkemy Capital Investments (ALK), Tufton Oceanic Assets (SHIP), Chenavari Toro Income Fund (TORO), CloudCoCo Group (CLCO), Iconic Labs (ICON), 22532 (PAA.L) (PAA), Greka Engineering & Technology (GEL), Marwyn Management Partners (MMP), and Anglo American (AAL). These companies are all part of the "transportation" industry. Provexis vs. Norish Alkemy Capital Investments Tufton Oceanic Assets Chenavari Toro Income Fund CloudCoCo Group Iconic Labs 22532 (PAA.L) Greka Engineering & Technology Marwyn Management Partners Anglo American Provexis (LON:PXS) and Norish (LON:NSH) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, community ranking, dividends and analyst recommendations. Does the media prefer PXS or NSH? In the previous week, Provexis' average media sentiment score of 0.00 equaled Norish'saverage media sentiment score. Company Overall Sentiment Provexis Neutral Norish Neutral Which has better valuation & earnings, PXS or NSH? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProvexis£426.17K34.47N/AN/AN/ANorish£36.39M0.00N/A£6.10N/A Does the MarketBeat Community prefer PXS or NSH? Provexis received 16 more outperform votes than Norish when rated by MarketBeat users. However, 68.18% of users gave Norish an outperform vote while only 64.21% of users gave Provexis an outperform vote. CompanyUnderperformOutperformProvexisOutperform Votes6164.21% Underperform Votes3435.79% NorishOutperform Votes4568.18% Underperform Votes2131.82% Is PXS or NSH more profitable? Norish has a net margin of 0.00% compared to Provexis' net margin of -73.10%. Norish's return on equity of 0.00% beat Provexis' return on equity.Company Net Margins Return on Equity Return on Assets Provexis-73.10% -138.67% -56.14% Norish N/A N/A N/A Do insiders & institutionals hold more shares of PXS or NSH? 7.9% of Provexis shares are held by institutional investors. 21.6% of Provexis shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryNorish beats Provexis on 5 of the 9 factors compared between the two stocks. Ad Porter & CompanyAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.I urge you to watch it now. Get Provexis News Delivered to You Automatically Sign up to receive the latest news and ratings for PXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PXS vs. The Competition Export to ExcelMetricProvexisDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£14.69M£1.17B£5.14B£1.88BDividend Yield5.06%3.04%5.09%5.68%P/E Ratio43.75131.2390.051,808.56Price / Sales34.471,981.001,117.00381,933.69Price / CashN/A10.2542.9628.33Price / BookN/A3.084.782.93Net IncomeN/A£152.21M£120.31M£156.72M7 Day Performance-4.06%-0.48%-1.92%-1.92%1 Month Performance41.61%-1.33%11.50%17.85%1 Year Performance18.18%99.54%30.59%29.41% Provexis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PXSProvexisN/AGBX 0.65flatN/A+8.3%£14.69M£426,168.0043.754Gap DownNSHNorishN/AGBX 175+775.0%N/A+0.0%£52.62M£36.39M28.691,251Gap UpALKAlkemy Capital InvestmentsN/AGBX 143.78+10.6%N/A+26.7%£12.67MN/A-606.3025,500Gap UpSHIPTufton Oceanic AssetsN/AGBX 1.20-0.5%N/A+23.8%£3.49M£39.75M9.9950TOROChenavari Toro Income FundN/AGBX 0.56-1.9%N/A+26.4%£1.71MN/A-18.97N/AGap UpCLCOCloudCoCo GroupN/AGBX 0.23-15.7%N/A-71.4%£1.59M£27.31M-115.00125Gap DownHigh Trading VolumeICONIconic LabsN/AGBX 5.25+144.2%N/A+27.3%£586,000.00£600,855.00-15.003Gap UpHigh Trading VolumePAA22532 (PAA.L)N/AN/AN/AN/A£0.00N/A0.004,100Gap UpHigh Trading VolumeGELGreka Engineering & TechnologyN/AN/AN/AN/A£0.00N/A0.002,110MMPMarwyn Management PartnersN/AN/AN/AN/A£0.00N/A0.001,660AALAnglo American1.1874 of 5 starsGBX 2,431-0.2%GBX 2,715+11.7%+21.7%£29.42B£29.44B-2,341.83129,700Insider TradeNews CoverageHigh Trading Volume Related Companies and Tools Related Companies Norish Alternatives Alkemy Capital Investments Alternatives Tufton Oceanic Assets Alternatives Chenavari Toro Income Fund Alternatives CloudCoCo Group Alternatives Iconic Labs Alternatives 22532 (PAA.L) Alternatives Greka Engineering & Technology Alternatives Marwyn Management Partners Alternatives Anglo American Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:PXS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provexis plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Provexis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PXS Stock Alerts